Elicio Therapeutics Inc. (ELTX)
NASDAQ: ELTX
· Real-Time Price · USD
11.78
1.94 (19.72%)
At close: Aug 18, 2025, 3:59 PM
11.85
0.64%
Pre-market: Aug 19, 2025, 07:00 AM EDT
Elicio Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M | -8.03M | -6.65M | -7.2M | -7.3M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
Depreciation & Amortization | 281K | 278K | 305K | 290K | 290K | 290K | 286K | 273K | 501K | 110K | -372.68K | 294K | 388.21K | 228K | 223K | 217K | 206K | 52.3K |
Stock-Based Compensation | 710K | 517K | 490K | 327K | 324K | 324K | 337K | 339K | 279K | 224K | 198.61K | 110K | 113K | 156.9K | 84.69K | n/a | n/a | 345.38K |
Other Working Capital | -179K | -3.35M | 4.63M | 833K | 1.32M | 502K | -1.59M | 4.62M | -929K | -507K | -912.35K | 322K | 284K | -301K | -28.43M | -85K | 2.06M | -1.06M |
Other Non-Cash Items | 971K | 649K | 780K | 9.17M | -3.59M | 1.85M | 75K | 98K | 719K | 342K | 86.84K | 1.08M | 6.99M | 1.76M | 5.27M | 4.13M | 1.65M | 777.6K |
Deferred Income Tax | n/a | n/a | n/a | 16K | n/a | n/a | -16K | n/a | n/a | n/a | 657.42K | 360K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -351K | -354K | 3.69M | 1.76M | 1.27M | -2.76M | -1.63M | 4.77M | -2.52M | -678K | -1.2M | -30K | 3.37M | -1.62M | -31.36M | -1.75M | 4.69M | -1.06M |
Operating Cash Flow | -8.95M | -10.12M | -8.74M | -7.27M | -8.93M | -12.12M | -9.9M | -5.18M | -9.47M | -8.14M | -7.28M | -5.39M | 6.14M | -15.65M | -14.36M | -15.2M | -10.53M | -6.07M |
Capital Expenditures | n/a | n/a | -45K | n/a | -42K | n/a | n/a | -45K | -4K | -17K | -94.84K | 559K | -559K | -508.17K | -36K | -61K | -244K | -75.85K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 42K | n/a | 3K | n/a | n/a | 10M | -10M | n/a | n/a | -4.12K | 4.12K | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -45K | n/a | -42K | 3K | n/a | -45K | 30K | -17K | -94.84K | 559K | -559K | -504.04K | -36K | -61K | -244K | -75.85K |
Debt Repayment | n/a | n/a | -19.73M | 19.73M | n/a | n/a | 10M | n/a | 3.27M | 10M | n/a | n/a | 14K | n/a | 293K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -150K | 150K | -150K | n/a | -233 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 19.73M | 10.98M | 13K | 5.96M | -10M | -10M | 31.64M | 40K | 65.23K | -61K | n/a | -14K | -3K | -92K | -1.22M | 170.25K |
Financial Cash Flow | 11.93M | 10.33M | 227K | 30.75M | 316K | 11.02M | 7M | 59K | 21.51M | 10.04M | 11.18M | 8.78M | 1.26M | -14K | 404K | 699K | -2.38M | 5.12M |
Net Cash Flow | 3.06M | 240K | -8.54M | 23.52M | -8.7M | -1.09M | -2.89M | -5.17M | 12.06M | 1.88M | 3.81M | 3.39M | -71.79M | -15.75M | -13.98M | -14.56M | n/a | -1.03M |
Free Cash Flow | -8.95M | -10.12M | -8.79M | -7.27M | -8.97M | -12.12M | -9.9M | -5.23M | -9.48M | -8.16M | -7.37M | -4.83M | 5.58M | -16.16M | -14.4M | -15.26M | -10.78M | -6.15M |